Purpose: Electropermeabilization has been used for the introduction of
genes into cells. Using this technique, we introduced the cytotoxic d
rug bleomycin (BLM) into cells and examined whether the technique migh
t be useful for the treatment of bladder cancer. Materials and methods
: For electropermeabilization in vitro, we used YTS-1 cells, a human t
ransitional cell carcinoma line. Aliquots of cell suspension were mixe
d with a solution of BLM and immediately exposed to electric pulses. A
high-power pulse generator was used to supply square-shaped pulses of
1250 V/cm (100 mu s, eight pulses). After a 2-h post-shock incubation
, cells were washed and incubated for one further hour. Then the conce
ntration of BLM in the cells was measured using a bioassay. For electr
opermeabilization of tissue, we used normal male Wistar rats. The blad
der was exposed and 10 mg/kg BLM was injected into the caudal vein. A
series of eight pulses with a time constant of 100 mu s at an electric
field intensity of 1000 V/cm was applied. The bladder, liver and lung
s were extracted 1 h later and prepared for quantification of the BLM
concentration using the bioassay. Results: Electrotreated cells contai
ned significantly higher concentrations of BLM than nonelectrotreated
cells. The concentration of BLM 1 h after electrotreatment in bladder
tissue was 2.7 times higher than that in nonelectrotreated bladder tis
sue. Conclusion: The electropermeabilization technique has the potenti
al to serve as a new and effective modality for the treatment of bladd
er cancer.